Kiniksa Pharmaceuticals International (KNSA) stock valuation

$95.55 Nov 18, 2026 · market cap $7.5B

8/121 investors
i

Kiniksa Pharmaceuticals International trades at $96. Our two models put it at $42–$106 (base $42): 128% above the base.

Cash Flow $106 · Buffett $42 · models run Nov 18, 2026

8 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate KNSACreate free account →

Full open-source research report for KNSA on DeepValues Research (CC BY 4.0)